Rapid Nutrition Completes First Manufacturing Run in China, Ready for Major Sales Events
Streamlined production in China set to deliver cost efficiencies and meet soaring demand across key global markets
London, United Kingdom – 28 October 2024 - Rapid Nutrition PLC (Euronext Growth Paris: ALRPD), is pleased to announce the successful completion of its first manufacturing run in China. This milestone positions the company to meet growing demand just in time for major sales events, with the first shipment due to arrive within two weeks.
The new production facility in China underscores Rapid Nutrition’s commitment to expanding in this key market, with cost savings projected at approximately 58%. CEO Simon St. Ledger commented, "This is a critical step in our growth strategy, allowing us to scale efficiently and capture a larger share of the booming Chinese market."
Chinese consumers value trust and high-quality international products, and Rapid Nutrition remains dedicated to upholding these principles with its premium health and wellness brands. This progress aligns with major upcoming sales events in the company’s other key markets, such as Black Friday and Cyber Monday, ensuring Rapid Nutrition is well-positioned to meet global demand during peak retail periods. As the company ramps up production, it remains focused on delivering value to both shareholders and consumers.
For further information about Rapid Nutrition PLC and its ongoing initiatives, please visit www.rnplc.com.
About Rapid Nutrition
Rapid Nutrition is a leading health and wellness company committed to providing innovative solutions for a healthier world. With a focus on research-backed formulas, we empower individuals to optimize their well-being and face life's challenges with confidence.
Investor Relations Contact:
Disclaimer
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.
This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).